Aortopathic effect of androgenic anabolic steroids.
Anabolic androgens
Aortic stiffness
Bodybuilding
Journal
Journal of echocardiography
ISSN: 1880-344X
Titre abrégé: J Echocardiogr
Pays: Japan
ID NLM: 101263153
Informations de publication
Date de publication:
06 2021
06 2021
Historique:
received:
03
08
2020
accepted:
01
10
2020
revised:
19
09
2020
pubmed:
13
10
2020
medline:
29
10
2021
entrez:
12
10
2020
Statut:
ppublish
Résumé
Anabolic androgens have been reported to be associated with cardiovascular complications. One study revealed that increase in vascular stiffness in bodybuilders is associated with anabolic androgens and improvement in vascular function may occur following anabolic androgens discontinuation. The aim of this study was to investigate any possible relation between aortic elastic properties and anabolic androgens. Study population was divided into 3 groups: Group-1 [n = 35] consisted of bodybuilders who denied any current or previous use of anabolic androgens. Group-2 [n = 18] was bodybuilders with regular using of anabolic androgens for at least 2 year prior to the start of our study. Group-3 was 13 healthy age-matched sedentary men as a control group. Cardiac echocardiography was performed in the bodybuilders and controls and indexes of aortic function were calculated. Aortic stiffness was approximately twofold higher in anabolic androgens user bodybuilders compared with drug-free bodybuilders [P < 0.001]. The present study demonstrates that chronic anabolic androgens use clearly produces significant decrease in the elastic properties of aorta.
Sections du résumé
BACKGROUND
Anabolic androgens have been reported to be associated with cardiovascular complications. One study revealed that increase in vascular stiffness in bodybuilders is associated with anabolic androgens and improvement in vascular function may occur following anabolic androgens discontinuation. The aim of this study was to investigate any possible relation between aortic elastic properties and anabolic androgens.
METHODS
Study population was divided into 3 groups: Group-1 [n = 35] consisted of bodybuilders who denied any current or previous use of anabolic androgens. Group-2 [n = 18] was bodybuilders with regular using of anabolic androgens for at least 2 year prior to the start of our study. Group-3 was 13 healthy age-matched sedentary men as a control group. Cardiac echocardiography was performed in the bodybuilders and controls and indexes of aortic function were calculated.
RESULTS
Aortic stiffness was approximately twofold higher in anabolic androgens user bodybuilders compared with drug-free bodybuilders [P < 0.001].
CONCLUSION
The present study demonstrates that chronic anabolic androgens use clearly produces significant decrease in the elastic properties of aorta.
Identifiants
pubmed: 33044714
doi: 10.1007/s12574-020-00495-5
pii: 10.1007/s12574-020-00495-5
doi:
Substances chimiques
Anabolic Agents
0
Testosterone Congeners
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
113-117Références
Wagman DF, Curry LA, Cook DL. An investigation into the anabolic androgenic steroid use by elite U.S. powerlifters. J Strength Cond Res. 1995;9:149–54.
Thiblin I, Lindquist O, Rajs J. Cause and manner of death among users of anabolic androgenic steroids. J Forensic Sci. 2000;45:16–23.
doi: 10.1520/JFS14635J
Parssinen M, Kujala U, Vartiainen E, Sarna S, Seppala T. Increased premature mortality of Competitive powerlifters suspected to have used anabolic agents. Int J Sports Med. 2000;21:225–7.
doi: 10.1055/s-2000-304
De Piccoli B, Giada F, Benettin A, Sartori F, Piccolo E. Anabolic steroid use in body builders: an echocardiographic study of left ventricle morphology and function. Int J Sports Med. 1991;12:408–12.
doi: 10.1055/s-2007-1024703
Urhausen A, Albers T, Kindermann W. Are the cardiac effects of anabolic steroid abuse in strength athletes reversible? Heart. 2004;90:496–501.
doi: 10.1136/hrt.2003.015719
Parssinen M, Seppala T. Steroid use and long-term health risks in former athletes. Sports Med. 2002;32:83–94.
doi: 10.2165/00007256-200232020-00001
Liu PY, Death AK, Handelsman DJ. Androgens and cardiovascular disease. Endocr Rev. 2003;24:313–40.
doi: 10.1210/er.2003-0005
McCrohon JA, Jessup W, Handelsman DJ, Celermajer DS. Androgen exposure increases human monocyte adhesion to vascular endothelium and endothelial cell expression of VCAM-1. Circulation. 1999;99:2317–22.
doi: 10.1161/01.CIR.99.17.2317
Alexandersen P, Haarbo J, Christiansen C. The relationship of natural androgens to coronary heart disease in males: a review. Atherosclerosis. 1996;125:1–13.
doi: 10.1016/0021-9150(96)05864-9
Kasikcioglu E. Anabolic androgenic steroids: a bad tenor for cardiovascular orchestra. Anadolu Kardiyol Derg. 2005;5:148–9.
pubmed: 15939696
Lane HA, Grace F, Smith JC, Morris K, Cockcroft J, Scanlon MF, Davies JS. Impaired vasoreactivity in bodybuilders using androgenic anabolic steroids. Eur J Clin Invest. 2006;36:483–8.
doi: 10.1111/j.1365-2362.2006.01667.x
Ferrer M, Encabo A, Marin J, Balfagon G. Chronic treatment with the anabolic steroid, nandrolone, inhibits vasodilator responses in rabbit aorta. Eur J Pharmacol. 1994;252:233–41.
doi: 10.1016/0014-2999(94)90602-5
Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M- Mode echocardiography: results of a survey of echocardiographic measurements. Circulation. 1978;58:1072–83.
doi: 10.1161/01.CIR.58.6.1072
Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anat Valid Method Circ. 1977;55:613–8.
Kosar F, Aksoy Y, Ozguntekin G, Yetkin E, Gunen H. C-reactive protein and aortic stiffness in patients with idiopathic dilated cardiomyopathy. Echocardiography. 2007;24:1–8.
doi: 10.1111/j.1540-8175.2006.00363.x
Gullu H, Erdogan D, Caliskan M, Tok D, Yildirim D, Ulus T, et al. Interrelationship between noninvasive predictors of atherosclerosis: transthoracic coronary flow reserve, flow mediated dilation, carotid intima-media thickness, aortic stiffness, aortic distensibility, elastic modulus, and brachial artery diameter. Echocardiography. 2006;23:835–42.
doi: 10.1111/j.1540-8175.2006.00342.x
Ozhan H, Yazici M, Albayrak S, Erbilen E, Bulur S, Akdemir R, et al. Elastic properties of the ascending aorta and left ventricular function in patients with hypothyroidism. Echocardiography. 2005;22:649–56.
doi: 10.1111/j.0742-2822.2005.00189.x
Oishi Y, Miyoshi H, Mizuguchi Y, Iuchi A, Nagase N, Oki T. Aortic stiffness is strikingly increased with age ≥ 50 years in clinically normal individuals and preclinical patients with cardiovascular risk factors: assessment by the new technique of 2D strain echocardiography. J Cardiol. 2011;57:354–9.
doi: 10.1016/j.jjcc.2010.12.003
Webb OL, Laskarzewski PM, Glueck CJ. Severe depression of high-density lipoprotein cholesterol levels in weight lifters and body builders by self-administered exogenous testosterone and anabolic androgenic steroids. Metabolism. 1984;33:971–5.
doi: 10.1016/0026-0495(84)90222-1
Ferenchick GS. Anabolic-androgenic steroids and thrombosis: is there a connection? Med Hypothesis. 1991;35:27–31.
doi: 10.1016/0306-9877(91)90079-E
McCredie RJ, McCrohon JA, Turner L, Griffiths KA, Handelsman DJ, Celermajer DS. Vascular reactivity is impaired in genetic females taking high-dose androgens. J Am Coll Cardiol. 1998;32:1331–5.
doi: 10.1016/S0735-1097(98)00416-1
Herman MS, Robinson JTC, McCredie RJ, Adams MR, Boyer MJ, Celermajer DS. Androgen deprivation is associated with enhanced endothelium-dependent dilatation in adult men. Arterioscler Thromb Vasc Biol. 1997;17:2004–9.
doi: 10.1161/01.ATV.17.10.2004
Webb CM, McNeill JG, Hayward CS, de Zeigler D, Collins P. Effects of testosterone on coronary vasomotor regulation in men with coronary heart disease. Circulation. 1999;100:1690–6.
doi: 10.1161/01.CIR.100.16.1690
Yue P, Chatterjee K, Beale C, Poole Wilson PA, Collins P. Testosterone relaxes rabbit coronary arteries and aorta. Circulation. 1995;91:1154–60.
doi: 10.1161/01.CIR.91.4.1154
Chou TM, Sudhir K, Hutchison SJ, et al. Testosterone induces dilation of canine coronary conductance and resistance arteries in vivo. Circulation. 1996;94:2614–9.
doi: 10.1161/01.CIR.94.10.2614
Green DJ, Cable NT, Rankin JM, Fox C, Taylor RR. Anabolic steroids and vascular responses (letter). Lancet. 1993;342:863.
doi: 10.1016/0140-6736(93)92720-E
Lartaud-Idjouadiene I, Lompré AM, Kieffer P, Colas T, Atkinson J. Cardiac consequences of prolonged exposure to an isolated increase in aortic stiffness. Hypertension. 1999;34(1):63–9.
doi: 10.1161/01.HYP.34.1.63